63 results
Page 2 of 4
424B5
b8f1l4phea273
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
ipw8sapu 1m
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
x8udo q5l
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
4j299
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
0d53ehmpk 84
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
EX-12.2
5mlpulye3k28e7hf
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
56ns747oaf8 k3el
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
ksydgs uaeuf21vvujuu
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
l5ox5oa i0rz0fal3
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
hmlnq2jjfd
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
2md8kp8mnl311av
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
srqxn
10 Jul 19
Prospectus supplement
8:18am
F-3
tefkqwdlz
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
5eigz44lsazmyww
7 Jun 19
Shelf registration (foreign)
3:31pm